Searched for
EMERGING MARKETS
Wockhardt expands novel antibiotic Miqnaf's access; Q2 revenue rises 24%Wockhardt has expanded its marketing access for Miqnaf in India following the removal of a supply condition. The company's biotechnology se...- How are equity investments taxed in India? A guide to capital gains taxIn a bid to invigorate domestic and foreign mutual fund investments, India's Securities and Exchange Board has put forth recommendations fo...
- Sebi backs removal of LTCG tax for foreign investors: ReportTo boost foreign investment interest, India's Securities and Exchange Board has put forth a proposal to scrap long-term capital gains tax f...
- FPI G-Sec outflows nearly halve to Rs 5,400 crore in OctoberForeign portfolio investors reduced their selling of Indian government securities and equities in October compared to September. Despite th...
- Nifty 50 vs S&P 500 vs Brazil Bovespa vs Japan Nikkei: Which share market performed the best in last 10 yearsWelcome to TrendMap, your quick guide to investment performance. This edition tracks 10 years of global equity returns. Currency fluctuatio...
- Elderly care industry eyes emerging companionship marketIn India, elderly companionship services face hurdles in building a dependable market, primarily due to the stigma linked to purchasing soc...
- Sun Pharma Q2 profit takes a hit on exceptional itemsSun Pharmaceutical has seen a notable 36% drop in net profit, juxtaposed with an 11.8% rise in consolidated revenue. The uplift in revenue ...
- Sun Pharma Q2 profit falls 36% as litigation costs hit earningsSun Pharma reported a 36% decline in Q2FY27 net profit to Rs 1,989 crore due to exceptional litigation and acquisition-related costs. Reven...
- SoftBank-backed OPay raises $304 million in US IPOThe Nigeria-focused firm sold 16 million American depositary shares at $19 apiece in the IPO, compared with its targeted range of $19 to $2...
- Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional chargesSun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported...
- Global FMCG giants find an Indian answer to their Western slowdownGlobal consumer giants including PepsiCo, Nestle, Unilever, Pernod Ricard and Coca-Cola are increasingly looking to India for growth as dem...
- From Patna to Kanpur, can an emerging market fix dirty, broken cities?Patna is set to become the first municipality in Bihar to issue municipal bonds, raising Rs 200 crore for urban infrastructure. This move h...
- Promoters key in emerging markets, professional management vital as firms grow: Anil AgarwalAnil Agarwal made a compelling case for the crucial impact of promoters in emerging markets, particularly India. He pointed out the differe...
- India only major emerging economy set to reduce debt ratio by 2031: RBI Deputy GovernorIndia is projected to be the only emerging market economy among nine economies with gross domestic product (GDP) exceeding USD 1 trillion t...
- Reckitt’s base effect GST boost in India to unwind in Q4, says CEOReckitt's India operations showed strong growth momentum in the July-September quarter compared to the previous year. The prior year was af...
- Global equity funds attract $28.16 billion as easing yields boost sentimentGlobal equity funds attracted $28.16 billion in weekly inflows as easing US Treasury yields and strong corporate earnings lifted investor s...
- Brazil stock market to crash today? What Lula’s surprise victory in elections means for emerging markets, commoditiesBrazil’s stock market faces a potential sharp selloff after President Luiz Inácio Lula da Silva’s surprise election victory dashed investor...
- India valuations hit 6-year low, but stocks still expensive than EM peersIndia's equity valuations have reached their lowest levels in six years after a recent market decline. Factors contributing to this decline...
- GLP-1 boom in China, India, Brazil could create $22 billion market by 2035, J.P. Morgan saysThe China-India-Brazil market for GLP-1 weight-loss drugs could expand to $22 billion by 2035 from $6.6 billion currently, J.P. Morgan esti...
- Fed sneezes, but emerging markets aren't catching a cold yet: McGeeverEmerging markets are displaying surprising economic resilience in light of the Federal Reserve's tightening measures. Stronger fiscal funda...
Load More
